Innovex Completes Sale of Dril-Quip Eldridge Facility
HOUSTON–(BUSINESS WIRE)–#innovex–Innovex International, Inc. (NYSE: INVX) (the “Company,” “Innovex” or “we”) announced that it has... Read more.
Pay Governance’s Tara Tays Named 2025 NACD Directorship 100™ Honoree
NEW YORK–(BUSINESS WIRE)–#PayGovernance–Tara Tays of Pay Governance, a top executive compensation consulting firm, has been named a 2025 NACD Directorship... Read more.
Cure Rare Disease Secures FDA Orphan Drug Designation for Investigational Gene Therapy to Treat Limb-Girdle Muscular Dystrophy Type R9 (LGMD2i/R9)
Designation supports development of CRD-003, an investigational therapy targeting the root cause of Limb-Girdle Muscular Dystrophy Type R9 WOODBRIDGE, Conn.–(BUSINESS... Read more.
Mirion To Acquire Paragon Energy Solutions, one of the Leading Providers of Highly Engineered Solutions for Large-scale Nuclear Power Plants and Small Modular Reactors (SMRs) in the United States
Broadens Mirion’s portfolio of offerings for nuclear power customers, including SMRs Attractive purchase price of $585 million in cash Accretive to diluted EPS... Read more.
Dynamo Software Receives Top Honors in ‘Data Management Insight Awards USA 2025’
Program Recognizes Leading Providers of Data Management Solutions in North America BOSTON–(BUSINESS WIRE)–#AlternativeInvestments—Dynamo Software... Read more.
Exchange Income Corporation Celebrates a Fourth Successful Season of the Atik Mason Indigenous Pilot Pathway, Offers Employment to Program Members, Including First Nunavut Graduate
WINNIPEG, Manitoba–(BUSINESS WIRE)–$EIF #TSX–As Canada’s National Day for Truth and Reconciliation approaches, Exchange Income Corporation... Read more.
Predictmedix AI Announces Multi-Vertical Growth Strategy to Become an AI Health-Technology Leader
Clinically validated SmartHealth AI Stations anchor expansion into Clinical-Trial Optimization and Consumer Digital Health, creating multiple recurring-revenue opportunities... Read more.
Acadia Pharmaceuticals Announces Phase 3 COMPASS PWS Trial of Intranasal Carbetocin (ACP-101) for Hyperphagia in Prader-Willi Syndrome Did Not Meet Primary Endpoint
SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced top-line results from the Phase 3 COMPASS PWS trial evaluating the... Read more.
Canopy Growth Announces Extension of Proxy Voting Deadline for Upcoming Annual General and Special Meeting
Shareholders now have until September 26, 2025 at 9:00 AM ET to submit votes to help ensure a quorum is achieved Your Vote is Important! If you need assistance with... Read more.
CORRECTING and REPLACING Hanshow Strengthens Global Ecosystem by Partnering with Glintt Life and shopreme to Drive Smart Retail Digitalization
PARIS–(BUSINESS WIRE)–Please replace the release with the following corrected version due to multiple revisions. The updated release reads: HANSHOW STRENGTHENS... Read more.